Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2022; 12(11): 97-102


Colorectal cytotoxic activities of phenolic constituents isolated from Euphorbia pseudocactus cultivated in Egypt

Mona Ismail, Marwa Hassan Ahmed, Mohamed Zaki, Abeer Moawad, Rabab Mohammed.




Abstract
Cited by 1 Articles

Investigation of the ethyl acetate (EtOAc) fraction of Euophorbia pseudocactus aerial parts family Euophorbiaceae were carried out, which resulted in isolation of eight phenolic compounds for the first time from E. pseudocactus. Identification was carried out using different chromatographic and spectroscopic techniques. The isolated compounds were kaempferol (1), ethyl gallate (2), gallic acid (3) astragalin (4), astragalin-6''-gallate (5), nicotiflorin (6), ellagic acid (7) and 1,2,3,4,6-pentagalloylglucose (8). The colorectal cytotoxic activity of the isolated phenolic compounds against LS-174T and LS-513(cecum) cell lines were tested using SRB assay. Results revealed that gallic acid possessed colorectal cytotoxic activity with IC50 of 18.27 µg/mL and 50.11 µg/mL against LS-174T and LS-513 cell lines; respectively, also ethylgallate showed cytotoxic activity against LS-174T cell line with IC50 of 25.42 µg/mL. Cytotoxic activity of other phenolic compounds against both cell lines was non-significant. These findings recommend gallic acid as anticancer lead compound.

Key words: Euophorbia pseudocactus; phenolic compounds, colorectal cytotoxic activity, SRB assay






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.